Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data
- 30 December 2020
- journal article
- research article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 44 (3), 103-110
- https://doi.org/10.1159/000513178
Abstract
Introduction: Medical care of soft-tissue sarcoma (STS) and bone sarcoma (BS) patients in Germany has rarely been investigated. The objectives of this article were (1) to investigate medical care and survival in STS and BS patients, and (2) to examine methodological aspects of corresponding analyses based on administrative healthcare data. Methods: We analyzed data from a statutory health insurance located in Saxony, Germany, covering approximately 2 million individuals. We identified incident STS and BS patients in the period 2012–2016 using 4 different case definitions. We examined treatment rates and visits to medical oncologists and medical practices descriptively, and then compared results between case definitions. We investigated survival prospects using a relative survival analysis and estimated hazard ratios (HRs) for risk factors for mortality using Cox regression. Results: Across case definitions, the number of included sarcoma patients (STS: n = 871–1,757; BS: n = 216–689) and applied treatments (STS: 42.2–83.1%; BS: 28.3–77.8%) varied substantially. Irrespective of the case definition, the minority of patients visited medical oncologists (STS: 9.8–10.8% BS: 4.4–7.9%) and “experienced” medical practices (STS: 27.7–38.4%; BS: 18.3–23.6%). Survival prospects were better for patients who visited “experienced” medical practices (STS: HR = 0.55; BS: HR = 0.42). Conclusion: Treatment rates clearly <100% and evidence from survival analyses indicate the potential for improvements in the care of sarcoma patients in Germany, e.g., by physicians in “experienced” medical practices.Keywords
This publication has 10 references indexed in Scilit:
- Evaluation of the accuracy of algorithms to identify soft tissue sarcoma (STS) in administrative claimsClinical Sarcoma Research, 2020
- Current State of Sarcoma Care in Germany: Results of an Online Survey of PhysiciansOncology Research and Treatment, 2019
- The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume InstitutionsSarcoma, 2018
- Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in GermanyBMC Public Health, 2018
- Epidemiology of Adult Soft-Tissue Sarcomas in GermanySarcoma, 2018
- Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysisEuropean Journal of Cancer Care, 2016
- ICD-Codierqualität ambulanter Krebsdiagnosen in GKV-RoutinedatenZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2016
- The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational frameworkJournal of Multidisciplinary Healthcare, 2015
- Gute Praxis Sekundärdatenanalyse (GPS): Leitlinien und EmpfehlungenDas Gesundheitswesen, 2015
- Health Service Use Among Patients With Chronic or Multiple Illnesses, and Frequent AttendersDeutsches Ärzteblatt international, 2012